F. ŞERMET Et Al. , "Short-Term outcomes of Aflibercept in eyes with wet age-related macular degeneration resistant to Ranibizumab Ranibizumab Tedavisine Dirençli Yaş Tip Yaşa Bagli Maköla Dejeneresansi Olgularinda Intravitreal Aflibercept Uygulamasinin Kisa Dönem Sonuçlari," Retina-Vitreus , vol.22, no.3, pp.179-183, 2014
ŞERMET, F. Et Al. 2014. Short-Term outcomes of Aflibercept in eyes with wet age-related macular degeneration resistant to Ranibizumab Ranibizumab Tedavisine Dirençli Yaş Tip Yaşa Bagli Maköla Dejeneresansi Olgularinda Intravitreal Aflibercept Uygulamasinin Kisa Dönem Sonuçlari. Retina-Vitreus , vol.22, no.3 , 179-183.
ŞERMET, F., DEMİREL, S., Bilici, S., & ÖZMERT, E., (2014). Short-Term outcomes of Aflibercept in eyes with wet age-related macular degeneration resistant to Ranibizumab Ranibizumab Tedavisine Dirençli Yaş Tip Yaşa Bagli Maköla Dejeneresansi Olgularinda Intravitreal Aflibercept Uygulamasinin Kisa Dönem Sonuçlari. Retina-Vitreus , vol.22, no.3, 179-183.
ŞERMET, FİGEN Et Al. "Short-Term outcomes of Aflibercept in eyes with wet age-related macular degeneration resistant to Ranibizumab Ranibizumab Tedavisine Dirençli Yaş Tip Yaşa Bagli Maköla Dejeneresansi Olgularinda Intravitreal Aflibercept Uygulamasinin Kisa Dönem Sonuçlari," Retina-Vitreus , vol.22, no.3, 179-183, 2014
ŞERMET, FİGEN Et Al. "Short-Term outcomes of Aflibercept in eyes with wet age-related macular degeneration resistant to Ranibizumab Ranibizumab Tedavisine Dirençli Yaş Tip Yaşa Bagli Maköla Dejeneresansi Olgularinda Intravitreal Aflibercept Uygulamasinin Kisa Dönem Sonuçlari." Retina-Vitreus , vol.22, no.3, pp.179-183, 2014
ŞERMET, F. Et Al. (2014) . "Short-Term outcomes of Aflibercept in eyes with wet age-related macular degeneration resistant to Ranibizumab Ranibizumab Tedavisine Dirençli Yaş Tip Yaşa Bagli Maköla Dejeneresansi Olgularinda Intravitreal Aflibercept Uygulamasinin Kisa Dönem Sonuçlari." Retina-Vitreus , vol.22, no.3, pp.179-183.
@article{article, author={FİGEN ŞERMET Et Al. }, title={Short-Term outcomes of Aflibercept in eyes with wet age-related macular degeneration resistant to Ranibizumab Ranibizumab Tedavisine Dirençli Yaş Tip Yaşa Bagli Maköla Dejeneresansi Olgularinda Intravitreal Aflibercept Uygulamasinin Kisa Dönem Sonuçlari}, journal={Retina-Vitreus}, year=2014, pages={179-183} }